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Detection of Bisphenol A and Derivatives in Human Urine via 
Cyclodextrin-Promoted Fluorescence Modulation  
Dana J. DiScenza,a Julie Lynch,a Ezra Feder,a and Mindy Levine*a 
Reported herein is the sensitive and selective detection of bisphenol A (BPA) and six BPA derivatives in buffer 
and urine environments. This detection system relies on the ability of γ-cyclodextrin to act as a supramolecular 
scaffold to promote highly analyte-specific, proximity-induced fluorescence modulation of high quantum yield 
fluorophores, which led to unique modulation responses for each cyclodextrin-analyte-fluorophore 
combination investigated in both buffer and urine environments, and high selectivity between structurally 
similar analytes using linear discriminant analysis of the resulting response signals. This method was sensitive 
(low micromolar detection limits), selective (able to differentiate between structurally similar analytes), and 
broadly applicable (with successful detection in both buffer and urine environments), and has significant 
potential in the detection of BPA and its derivatives in a wide variety of complex environments. 
Introduction 
Among the list of known and suspected environmental toxicants, 
bisphenol A (BPA) and its derivatives,1 including bisphenol S (BPS) 
and bisphenol F (BPF),2 have received a significant amount of 
attention in both the scientific literature3 and the popular media. 
BPA is a suspected endocrine disruptor,4 and exposure to BPA and 
associated derivatives is correlated with increased rates of asthma,5 
inflammatory bowel disease,6 endocrine disorders,7 and certain 
cancer sub-types.8 These negative health effects are particularly 
concerning because of BPA’s ubiquitous presence in a variety of 
commercial products, including plastic water bottles9 and bags,10 
liners of canned food products,11 infant bottles12 and training (i.e. 
“sippy”) cups,13 and cash register receipts.14  
As a result of these deleterious health effects, many regulatory 
agencies have banned the use of BPA in commercial products.15 
Manufacturers have replaced BPA with a variety of alternatives;16 
however, the use of BPA-like derivatives are particularly concerning 
due to the limited amount of toxicity data associated with these 
compounds,17 and the fact that available data suggests that BPA 
derivatives can be even more toxic than BPA itself.18 
There are almost no regulations associated with the use of BPA 
derivatives to date, nor are there any detailed regulations about the 
use of the label “BPA-free” on commercial products, which means 
that products that are labelled as “BPA-free” may contain significant 
amounts of BPA and BPA derivatives.19 One biological fluid that is 
particularly important for the detection of BPA and BPA derivatives 
is human urine, due to the non-invasive sample collection 
procedures and the relative simplicity of the matrix compared to 
other biological fluids.20 BPA and its derivatives have been found in 
the urine of about 90% of the U.S. population.21 The relative dearth 
of regulations around BPA labelling,22 combined with the known and 
suspected deleterious health effects of BPA exposure,23 and 
prevalence of BPA and its derivatives in human urine, means that 
methods for BPA detection that are sensitive, selective, rapid, and 
practical for real-world usage are sorely needed. 
Reported methods for the detection of BPA and BPA derivatives 
focus predominantly on the use of mass spectrometry based 
methods, including gas chromatography-mass spectrometry (GC-
MS)24 and high-pressure liquid chromatography (HPLC)25 with mass 
spectrometry detection.26 While these methods provide exquisite 
sensitivity for even trace amounts of BPA, their use comes with 
significant drawbacks in terms of the cost associated with such 
methods, the level of expertise required to operate this 
instrumentation, and the time required to achieve high levels of 
purification that enable such sensitive detection. Newer methods, 
including electrochemical assays,27 colorimetric detection,28 and 
Raman spectroscopy-based methods,29  have also been reported. 
Previous work in our group has focused on the detection of a variety 
of aromatic and non-aromatic toxicants, using cyclodextrin-
promoted energy transfer30 (for photophysically active toxicants) 
and cyclodextrin-promoted fluorescence modulation (for non-
photophysically active analytes) (Fig. 1).31  
a. Department of Chemistry, University of Rhode Island, 140 Flagg Road, Kingston, 
RI 02881; mindy.levine@gmail.com; 401-874-4243 
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Fig. 1 Schematic of cyclodextrin-promoted (A) energy transfer and (B) fluorescence 
modulation 
We demonstrated that this toxicant detection system operates in a 
broad range of environments, including plasma,32 breast milk,33 and 
urine,34 as well as in extracts collected in the aftermath of the 2010 
Deepwater Horizon oil spill.35  Although our previous work detected 
polycyclic aromatic hydrocarbons,36 polychlorinated biphenyls,37 
aromatic amines, pesticides,38 aliphatic alcohols, and fuel spill 
components, we have not used cyclodextrin systems for the 
detection of BPA and BPA derivatives to date.  
Reported herein is the rapid, sensitive, and selective detection of BPA 
and BPA derivatives in buffer and urine environments using 
cyclodextrin-promoted fluorescence modulation. This detection 
system uses commercially-available cyclodextrin hosts and 
fluorophore dyes to facilitate such detection. This method operates 
with high sensitivity (low micromolar detection limits), high 
selectivity (100% differentiation between structurally similar 
analytes), and general applicability (100% differentiation between 
binary mixtures of structurally similar analytes). 
Experimental  
Instruments and Reagents 
All analytes and fluorophores (compounds 1-11, Fig. 2) were 
purchased from Sigma-Aldrich Chemical Company and used as 
received, unless otherwise noted. γ-Cyclodextrin was purchased 
from Tokyo Chemical Industry and used as received. UV-Visible 
spectra were obtained using an Agilent 8453 UV/Visible 
spectrometer. Fluorescence spectra were obtained using a Shimadzu 
RF-5301PC spectrophotofluorimeter with 1.5 nm excitation and 
emission slit widths. All GC-MS measurements were obtained used a 
Shimadzu GC-MS QP2020 gas chromatograph-mass spectrometer. 
Urine was obtained from a single anonymous human donor and 
stored in amber high-density polyethylene bottles in the refrigerator 
until use. Computational experiments were performed using Spartan 
16 software. Arrays were generated using SYSTAT 13 statistical 
computing software. 
 
Fig. 2 Structures of analytes 1-7, control analyte 8, and fluorophores 9-11 
General Procedure for GC-MS Characterization Experiments 
GC-MS sample preparation was conducted following literature-
reported procedures.39 Approximately 10 mL of the urine sample was 
added to a separatory funnel. Then, 15 mL of dichloromethane was 
added to the separatory funnel, and the separatory funnel was 
shaken vigorously. The organic layer was collected, and another 15 
mL of dichloromethane was added to the urine layer. The organic 
layer was collected, another 15 mL of dichloromethane was added to 
the urine, and the procedure was repeated. The remaining organic 
layer was dried with MgSO4, filtered, concentrated to 1 mL using a 
rotary evaporator, and analysed by GC-MS. 
All GC-MS measurements were obtained on a Shimadzu QP2020 gas 
chromatograph-mass spectrometer with the following settings: 
column: Shimadzu SH-Rxi-5SilMS (30 m x 0.25 mm x 0.25 µm); oven 
temperature: 45 oC, hold for 7 min, ramp to 200 oC at 20 oC/min, hold 
for 60 min; injection temperature: 200 oC; splitting ratio: splitless; MS 
ion source temperature: 230 oC; interface temperature: 150 oC; total 
run time: 75 min. 
General Procedure for Fluorescence Modulation Experiments 
In a quartz cuvette, 1.25 mL of a 10 mM γ-cyclodextrin solution 
dissolved in phosphate buffered saline (PBS) and 1.25 mL of a urine 
sample were combined and mixed thoroughly. For control 
experiments in the absence of urine, 2.5 mL of a γ-cyclodextrin 
solution was used. Next, 100 µL of a 0.1 mg/mL fluorophore solution 
in tetrahydrofuran (THF) was added, and the solution was excited 
four times at the excitation wavelength of the fluorophore (460 nm 
for fluorophores 9 and 10 and 420 nm for fluorophore 11). Then, 50 
µL of analytes 1-8 (1.0 mg/mL solution in THF) were added to the 
mixture, and the resulting solution was excited four times at the 
excitation wavelength of the fluorophore. The fluorescence emission 
spectra were integrated vs. wavenumber on the X-axis using 
OriginPro software, and the fluorescence modulation was measured 
by the ratio of the integrated emission of the fluorophore in the 
presence of the analyte to integrated emission of the fluorophore in 
the absence of the analyte, as shown in Equation 1: 
Fluorescence modulation = Flanalyte/Flblank                 (Eq. 1) 
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Where Flanalyte is the integrated fluorescence emission of the 
fluorophore in the presence of analyte, and Flblank is the integrated 
fluorescence emission of the fluorophore in the absence of the 
analyte. Fluorescence modulation ratios greater than 1 indicate an 
enhancement of fluorescence emission of the fluorophore in the 
presence of analyte, fluorescence modulation ratios less than 1 
indicate a decrease in fluorescence emission of the fluorophore in 
the presence of analyte, and fluorescence modulation ratios close to 
1 indicate minimal change in fluorescence emission of the 
fluorophore in the presence of analyte. 
General Procedure for Limit of Detection Calculations 
The limit of detection (LOD) is defined as the lowest concentration of 
analyte at which a signal can be detected. To determine this value, 
the following steps were performed for each water-cyclodextrin-
analyte combination.40 In a quartz cuvette, 1.25 mL of 10 mM γ-
cyclodextrin in PBS and 1.25 mL of urine sample were combined. In 
the absence of urine, 2.5 mL of γ-cyclodextrin solution was used. 
Then, 100 μL of a fluorophore 9 (0.1 mg/mL solution in THF) was 
added, the solution was excited at 460 nm, and the fluorescence 
emission spectra were recorded. Six measurements were taken. 
Next, 20 μL of analyte (1.0 mg/mL in THF) were doped into an 
aqueous sample, and again the solution was excited at the 
fluorophore’s excitation wavelength, and the fluorescence emission 
spectra were recorded. Six repeat measurements were taken. This 
step was repeated for 40 μL of analyte, 60 μL of analyte, 80 μL of 
analyte, and 100 μL of analyte, all of which were doped into a urine 
sample that did not initially contain toxicants, to measure the ability 
of the system to detect the doped toxicants within the complex 
aqueous matrix. 
All of the fluorescence emission spectra were integrated vs. 
wavenumber on the X-axis using OriginPro software, and calibration 
curves were generated. The curves were plotted with the analyte 
concentration in μM on the X-axis, and the fluorescence modulation 
ratio on the Y-axis. The curve was fitted to a straight line and the 
equation of the line was determined (see ESI for full details). The limit 
of detection was calculated according to Equation 2: 
LOD= 3(SDblank)/m                (Eq. 2) 
Where SDblank is the standard deviation of the blank, analyte-free 
sample and m is the slope of the calibration curve. All LODs were 
reported in μM. 
General Procedure for Array Generation Experiments 
Array analysis was performed using SYSTAT 13 statistical computing 
software with the following settings: (a) Classical discriminant 
analysis; (b) Grouping variable: analytes; (c) Predictors: fluorophores; 
and (d) Long-range statistics: Mahal  
General Procedure for Binding Constant Experiments 
In a quartz cuvette, 2.5 mL of PBS and 50-100 µM of analyte were 
combined and mixed thoroughly. The absorbance of the sample was 
measured across the full UV and visible range. This procedure was 
repeated for 5.00 x 10-6 M, 1.00 x 10-5 M, 5.00 x 10-5 M, 1.00 x 10-4 
M, 5.00 x 10-4 M, 1.00 x 10-3 M, 1.50 x 10-3 M, and 2.50 x 10-3 M γ-
cyclodextrin in PBS with constant analyte concentration (see ESI for 
full details). Double reciprocal Benesi-Hildebrand plots were 
generated following literature-reported procedures.41 Binding 
constants were calculated using Equation 3: 
1/ΔA = 1/bΔ𝜺𝜺[G][H]0Ka + 1/bΔ𝜺𝜺[H]0             (Eq. 3) 
Where A is the change in absorbance, specifically the absorbance of 
analyte in the presence of cyclodextrin minus  the absorbance of 
analyte in the blank, cyclodextrin-free sample in absorbance units, b 
is the path length of 1 cm, Δ𝜺𝜺 is the change in the absorption 
coefficient of the analyte-cyclodextrin complex minus the absorption 
coefficient of the analyte in cyclodextrin-free solution in L·cm-1·mol-
1, [G] is the cyclodextrin concentration in molar (M), [H]0 is the 
analyte concentration, and Ka is the binding constant in M-1. 
Results and discussion 
Urine Characterization 
GC-MS was used to characterize the analyte-free urine sample (Fig. 
3). 
 
Fig. 3 GC-MS spectrum of human urine sample 
The undoped urine sample showed peaks that corresponded to 
long-chain alkanes, fatty acids, and amides, all of which are 
commonly found in urine.42 Notably, the urine sample also 
contained GC-MS peaks that corresponded to benzophenone,43 
commonly used in personal care products such as sunscreen44 
and lip balm,45 phthalates, commonly found in plastics46 and 
some food products,47 and acetaminophen, commonly found in 
over-the-counter pain relievers.48 
Selection of Fluorophores 
Previous work in our group focused on the use of a BODIPY 
fluorophore with a free thiol moiety, which was synthesized in 
several steps. In order to develop more practically applicable 
detection systems, this work uses commercially available BODIPY 
compounds (fluorophores 9 and 10), as well as coumarin 6 
(fluorophore 11), which is commercially available, and has high 
quantum yields and excellent aqueous stability.  
Selection of Cyclodextrins 
Previous work in our group has used of a variety of commercially 
available cyclodextrins: α-cyclodextrin, β-cyclodextrin, randomly 
methylated β-cyclodextrin (with an average of 1.8 methyl groups per 
unit,)49 2-hydroxypropyl-β-cyclodextrin, and γ-cyclodextrin, for 
cyclodextrin-promoted energy transfer and fluorescence 
modulation.  
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Table 1 Calculated properties of analytes and fluorophores 
Compound Areaa 
(Å2) 
Solvent-
accessible 
surface 
areaa 
(Å2) 
Volumea 
(Å3) 
Binding in γ-
cyclodextrinb 
(M-1) 
Electrostatic 
potentialc 
(min/max) 
(kJ mol-1) 
 
1 245 179 246 3.22 x 104 -141/273  
2 259 184 265 2.37 x 104 -139/273  
3 220 171 210 1.39 x 104 -139/273  
4 233 179 225 1.79 x 104 -200/313  
5 260 178 261 7.83 x 104 -122/295  
6 295 214 307 5.99 x 104 -139/275  
7 344 254 367 1.06 x 105 -140/275  
8 104 84 86.3 c -139/68.2  
9d 262 194 266 5.33 x 103 -231/121  
10d 313 221 329 c -229/127  
11d 344 261 349 1.75 x 104 -202/118  
aValues were calculated using Spartan 16 software. bBinding constants calculated 
by UV/Visible spectroscopy (see ESI for more details). cNo binding constant value 
was obtained. d Binding constants measured by fluorescence spectroscopy. 
Table 2 Literature-reported dimensions of γ-cyclodextrina 
Compound Outer 
diameter 
(Å) 
Cavity 
diameter 
(Å) 
Height of 
torus (Å) 
Cavity 
volume 
(Å3) 
γ-cyclodextrin 17.5 7.5-8.3 7.9 427 
aValues were obtained from the literature50 
Due to the relatively large size of the analytes and the fluorophores 
in this system, γ-cyclodextrin was selected (Table 1 and Table 2). Of 
note, increases in the fluorophore emission intensity were observed 
in the presence of γ-cyclodextrin compared to in cyclodextrin-free 
solution, even in the absence of any added analyte (see ESI for more 
details). These increases can be attributed to the fact that binding in 
the cyclodextrin cavity decreases non-radiative decay pathways for 
the fluorophores and increases the resultant quantum yield, a 
phenomenon which has been observed previously.51  
Fluorescence Modulation 
Fluorescence modulation experiments measure the ability of a 
particular analyte to induce measurable, analyte-specific changes in 
the fluorescence emission spectra of a high quantum yield 
fluorophore. Micromolar concentrations of analytes 1-7 or control 
analyte 8 were added to each cyclodextrin-fluorophore combination 
or urine-cyclodextrin-fluorophore combination. The degree of 
fluorescence modulation of fluorophores 9-11 in the presence of and 
absence of analyte was calculated using Eq. 1.  
Based on computational results, it is evident that both the analyte 
and fluorophore do not bind in the cyclodextrin cavity together due 
to lack of available space (Table 1, Table 2). Nonetheless, the addition 
of analyte promotes binding of the fluorophore, via mechanisms that  
Table 3 Fluorescence modulation values for analytes 1-8 with fluorophore 9a  
Analyte Buffer Urine 
1 1.19 ± 0.01 1.36 ± 0.02 
2 1.20 ± 0.00 1.36 ± 0.02 
3 1.68 ± 0.01 1.85 ± 0.01 
4 1.19 ± 0.00 1.34 ± 0.01 
5 1.18 ± 0.00 1.38 ± 0.01 
6 1.19 ± 0.01 1.39 ± 0.01 
7 1.18 ± 0.01 1.36 ± 0.01 
8 1.17 ± 0.01 1.32 ± 0.00 
aAll results represent an average of results from four trials for each sample. 
Fluorescence modulation values were calculated using Eq. 1.  
we are still investigating, leading to subsequent increases in 
fluorescence emission of the fluorophore. It is important to note that 
while experimental conditions (i.e. temperature, pH, solvent, etc.) 
have an effect on the fluorescence modulation response in general,52 
our system controls these particular experimental parameters both 
before and after analyte addition so that they remain consistent.. 
Specifically in the case of fluorophore 9, the fluorescence modulation 
values were greater than 1, indicating that introduction of analytes 
1-7 and control analyte 8 led to an increase in the fluorescence 
emission of fluorophore 9 (Table 3). In this three-component system 
(analyte, fluorophore 9, and cyclodextrin), the effect of analyte 
addition is to promote binding of the fluorophore inside the 
cyclodextrin cavity, resulting in the observed fluorescence increases. 
Of note, the fluorescence modulation values in urine were uniformly 
higher than the values obtained in buffer, meaning that analyte 
addition in urine caused a larger increase in fluorescence compared 
to the fluorescence increases in buffer (see ESI for more details). 
Known differences in the composition of urine compared to buffer 
include higher concentrations of electrolytes as well as a lower pH 
value. For both factors, the net result is an increase in the 
concentration of charged species in solution, which can cause salt-
induced increases in key intermolecular interactions, including 
hydrophobic association and intermolecular hydrogen bonding, 
following literature precedent.53 
In comparing the fluorescence modulation values of different 
analytes, many of the analytes induce similar fluorescence changes, 
which again can be attributed to their ability to promote binding of 
the fluorophore 9 in the cyclodextrin cavity (Fig. 4).  
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Fig. 4 Fluorescence changes of fluorophore 9 (λex = 460 nm) in (A) buffer and (B) urine 
with analytes 1, 3, 5, and 8. The black line represents analyte 1, the red line represents 
analyte 3, the blue line represents analyte 5, and the purple line represents analyte 8. 
Table 4 Fluorescence modulation values for analytes 1-8 with fluorophore 10a 
Analyte Buffer Urine 
1 1.03 ± 0.00 1.03 ± 0.00 
2 0.86 ± 0.01 0.95 ± 0.00 
3 0.68 ± 0.01 0.92 ± 0.01 
4 0.84 ± 0.00 0.92 ± 0.01 
5 0.83 ± 0.00 0.94 ± 0.01 
6 0.84 ± 0.01 0.99 ± 0.01 
7 0.81 ± 0.01 0.90 ± 0.00 
8 1.03 ± 0.01 1.09 ± 0.01 
aAll results represent an average of results from four trials for each sample. 
Fluorescence modulation values were calculated using Eq. 1.  
Particularly high modulation values were observed for bisphenol F 
(analyte 3), which is the only analyte that has no substitution at the 
methylene position. This structural anomaly, in turn, likely means 
that it has less steric hindrance and dimensions that enable it to bind 
in or associate close to the γ-cyclodextrin cavity with fluorophore 9.  
(Table 1, Table 2, Fig. 5). In contrast, the substitution of the 
methylene position with other analytes means that such ternary 
complex formation is less favored, and that other differences in 
substitution patterns (analyte 1 vs analyte 5, for example) lead to 
minimal differences in the modulation values. 
 In most cases, the fluorescence modulation values for fluorophore 
10 were less than 1, indicating that introduction of analytes 1-7 and 
control analyte 8 led to a decrease in the fluorescence emission of 
fluorophore 10 (Table 4). The responses for fluorophore 10 indicated 
the presence of a fluorophore excimer peak (Fig. 6), as a result of the 
binding of two molecules of fluorophore 10 in the γ-cyclodextrin 
cavity. In such cases, introduction of the bisphenol analyte leads to 
the replacement of one of the two fluorophores from the cavity, 
leading to a decrease in the excimer emission and fluorescence 
modulation responses lower than 1.  
 
Fig. 5 Electrostatic potential maps of (A) analyte 1, (B) analyte 3, and (C) analyte 5. All 
surfaces were generated using energy minimized geometries. 
 
Fig. 6 Fluorescence changes of fluorophore 10 (λex = 460 nm) in (A) buffer and (B) urine 
with analytes 7 and 8. The black line represents no analyte, the red line represents 
analyte 7, and the blue line represents analyte 8. 
In every case, the fluorescence modulation values for fluorophore 11 
were greater than 1, indicating that introduction of analytes 1-7 and 
control analyte 8 led to an increase in the fluorescence emission of 
fluorophore 11 (Table 5). These increases were generally lower in the 
magnitude that the increases observed for fluorophore 9, indicating 
that the analyte-induced changes in the binding of fluorophore 11 in 
the cavity were lower than those of fluorophores 9 and 10. 
Additionally, the signal-to-noise ratio of all spectra containing 
fluorophore 11 is lower than spectra obtained in the presence of 
fluorophores 9 and 10. This different behaviour is likely a result of 
the fact that fluorophores 9 and 10 have higher quantum yields 
compared to fluorophore 11 and are also markedly more 
hydrophobic and larger in size compared to fluorophore 11,54 and 
that as a result of both of these features, binding of fluorophore 11 
in the γ-cyclodextrin cavity is more highly favoured. In support of this 
statement, electrostatic potential mapping of fluorophore 11 and 
fluorophores 9 and 10 show marked differences, both in terms of 
variation in electrostatic potential as well as in overall size and shape 
of the fluorophore (Fig. 7). These marked differences in the 
electrostatic potentials as well as solvent accessible surface areas 
(Table 1) contribute to the differences in interactions for each 
cyclodextrin-fluorophore-analyte combination. Fluorophore 11 has a 
number of advantages in terms of detection applications (high 
quantum yield, aqueous stability, etc), and our group has used it 
previously for a variety of turn-on detection schemes. The 
differential performance of fluorophores 9 and 10 compared to 
fluorophore 11 in this context provides important information for the 
array-based selectivity. 
Array Generation  
The selectivity of this system for structurally similar bisphenol 
derivatives was determined using array-based analysis of the 
fluorescence response patterns. This analysis resulted in 100% 
differentiation between analytes in both purified buffer and urine 
(Fig. 8A and 8C). The response patterns are markedly distinct for 
buffer and urine environments, and show unique, well-separated 
signals for structurally similar bisphenols within each sample. The 
high degree of success and noticeable visual differences between 
environments highlight the power of this statistical method in 
distinguishing even very slight structural differences (analytes 1 and 
2, analytes 1 and 5, and analytes 6 and 7). Given the high degree of 
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fluorescence modulation of fluorophores 9 and 10 and slight change 
of fluorescence of fluorophore 11, arrays were also generated using 
only data from fluorophores 9 and 10 (Fig. 8B and 8D). Interestingly, 
these arrays led to 88% differentiation between analytes. These 
arrays are visually different than the arrays generated using 
fluorophores 9-11 as predictors. There is more clustering between 
analytes, indicating poor separation between structurally similar 
analytes. This indicates that although the changes in fluorescence 
emission of fluorophore 11 upon analyte addition are minimal, they 
add more information and enable effective separation between 
structurally similar analytes. 
Table 5 Fluorescence modulation values for analytes 1-8 with fluorophore 11a 
Analyte Buffer Urine 
1 1.06 ± 0.00 1.08 ± 0.00 
2 1.08 ± 0.01 1.08 ± 0.01 
3 1.07 ± 0.01 1.08 ± 0.00 
4 1.07 ± 0.002 1.08 ± 0.00 
5 1.07 ± 0.003 1.07 ± 0.00 
6 1.07 ± 0.003 1.05 ± 0.01 
7 1.09 ± 0.004 1.08 ± 0.01 
8 1.09 ± 0.01 1.08 ± 0.00 
aAll results represent an average of results from four trials for each sample. 
Fluorescence modulation values were calculated using Eq. 1. 
 
Fig. 7 Electrostatic potential maps of (A) fluorophore 9, (B) fluorophore 10, and (C) 
fluorophore 11. All surfaces were generated using energy minimized geometries. 
 
Fig. 8 Array-based detection of analytes 1-8 in (A) buffer with fluorophores 9-11 as 
predictors; (B) buffer with fluorophores 9 and 10 as predictors; (C) urine with 
fluorophores 9-11 as predictors; and (D) urine with fluorophores 9 and 10 as predictors. 
In complex samples, such as human urine, it is likely multiple 
bisphenol analogues will be present in the event of an exposure 
event, or from cumulative exposure to bisphenol-containing 
consumer products. To address this issue, we tested the ability of our 
array-based detection system to differentiate between binary 
mixtures of bisphenol analytes (Fig. 9). Interestingly, analyte 
mixtures grouped on one side of the array, and samples containing 
one single analyte grouped on the other side of the array. This array 
corresponded to 100% differentiation between analyte mixtures and 
single analytes. Current work in our laboratory is focused on 
expanding these studies to include ternary and quaternary mixtures 
of analytes as well as different ratios of analytes in each mixture. 
Limit of Detection 
In addition to the ability to selectively differentiate between 
structurally similar analytes, it is important to be able to detect these 
compounds at low levels. The sensitivity of the system was 
determined by calculating limits of detection for all samples with 
fluorophore 9 following literature-reported procedures.  
Fluorophore 9 was chosen for these experiments because 
interactions with fluorophore 9 led to the highest degree of 
fluorescence modulation therefore indicating extremely sensitive 
detection. The results of these studies are summarized in Table 6.  
In general, the limits of detection for analytes in urine were slightly 
higher than those measured in purified buffer solutions. This is likely 
a result of the higher innate levels of nonpolar molecules that may 
compete with analytes for binding in the cyclodextrin cavity. These 
interactions can interfere with favourable intermolecular 
interactions and slightly lower the system sensitivity. While our low 
 
Fig. 9 Array-based detection of binary mixtures of analytes in urine using fluorophores 
9-11 as predictors 
Table 6 LODs for analytes 1-7 with fluorophore 9 in buffer and urinea 
Analyte LOD in Buffer (ppm) LOD in Urine (ppm) 
1 1.51 ± 0.05 1.82 ± 0.03 
2 0.14 ± 0.00 2.30 ± 0.03 
3 0.01 ± 0.00 0.40 ± 0.01 
4 0.29 ± 0.00 0.57 ± 0.00 
5 0.39 ± 0.01 0.84 ± 0.01 
6 0.49 ± 0.02 2.80 ± 0.04 
7 0.39 ± 0.01 0.28 ± 0.01 
aLODs were calculated using the procedures.40 See Electronic Supporting 
Information for full details.  
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part-per-million range detection limits show promise for the use of 
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per-billion range.55 Current efforts in our laboratory are focused on 
lowering detection limits for cases where the detection limits are 
above the literature-reported exposure limits by looking at other 
cyclodextrin-fluorophore combinations, and/or employing a 
preconcentration step to achieve optimal sensitivities. 
Conclusions 
In summary, cyclodextrin-promoted fluorescence modulation can be 
used for the detection of BPA and its derivatives in both buffer and 
urine environments. This method is sensitive (low micromolar 
detection limits), selective (able to differentiate between structurally 
similar analytes), and broadly applicable (success in detecting 
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